Clinical Trials · NCT01819285

Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Enrollment
985
Start date
Feb 1990
Locations
See registry
Primary endpoint
Overall survival
View Gonadorelin compound reference